THE VALUE OF PROSTATIC URETHRAL TUR BIOPSIES TAKEN BEFORE RADICAL CYSTOPROSTATECTOMY AND INTRAOPERATIVE FROZEN BIOPSY SAMPLES AND URETHRAL RECURRENCE

Size: px
Start display at page:

Download "THE VALUE OF PROSTATIC URETHRAL TUR BIOPSIES TAKEN BEFORE RADICAL CYSTOPROSTATECTOMY AND INTRAOPERATIVE FROZEN BIOPSY SAMPLES AND URETHRAL RECURRENCE"

Transcription

1 Y. ÖZCAN Adı, Y. KILIÇ, Adı YAŞAR BEDÜK, KADİR TÜRKÖLMEZ, JOURNAL SÜMER OF BALTACI, ANKARAMEDICAL C. ORHUN ECEMİŞ, SCHOOL MURAT AKAND, Vol 26, A. No HAKAN 1, 2004 HALİLOĞLU, HALİT TALAS THE VALUE OF PROSTATIC URETHRAL TUR BIOPSIES TAKEN BEFORE RADICAL CYSTOPROSTATECTOMY AND INTRAOPERATIVE FROZEN BIOPSY SAMPLES AND URETHRAL RECURRENCE Özcan Kılıç* Yaşar Bedük** Kadir Türkölmez*** Sümer Baltacı** C. Orhun Ecemiş* Murat Akand* A. Hakan Haliloğlu* Halit Talas* SUMMARY In this study, the value of preoperative TUR biopsies taken from prostatic urethra of the patients that have had radical cystoprostatectomy because of bladder cancer in determining the prostatic urethral involvement and the effect of prostatic urethral TUR biopsy with intraoperative frozen biopsy of surgical margin of prostatic urethra in selecting the type of urinary diversion and urethral recurrence are investigated. 35 male patients were included into the study. Prostatic urethral TUR biopsies before the cystoprostatectomy operation and intraoperative prostatic urethral surgical margin biopsies were taken from all of the patients. In radical cystoprostatectomy materials; superficial involvement in prostatic urethra was found in 9 (25.7%) patients and in 26 (74.3%) patients there were no prostatic urethral involvement. The sensitivity of TUR prostatic biopsies for determining the prostatic urethral involvement is 78%, the specificity is 92%, positive predictive value is 78% and the negative predictive value is 92%. 33 (94.3%) of the prostatic urethral surgical margin biopsies that are taken intraoperatively were negative and 2 (5.7%) were positive. There was prostatic urethral involvement in 2 patients who had a positive surgical margin previously. The predictive value of preoperative TUR biopsies taken from prostatic urethra for determining the involvement of prostatic urethra is high and useful for informing the patients about the type of urinary diversion. The superficial involvement of prostatic urethra is not an indication for urethrectomy and also it is not an handicap for orthotopic diversion. Biopsy specimens that are taken intraoperatively from prostatic urethral surgical margin is effective for determining urethral surgical margin involvement and decision for performing an urethrectomy and also orthotopic urinary diversion. Key Words: Bladder Cancer, Prostatic Urethral TUR Biopsy, Radical Cystoprostatectomy, Urethral Frozen Biopsy, Urethral Recurrence. ÖZET Radikal Sistoprostatektomi Öncesi Alınan Prostatik Üretral TUR Biyopsiler ve İntraoperatif Frozen Biyopsilerin Değeri ve Üretral Rekürrens Bu çalışmada, mesane kanseri nedeniyle radikal sistoprostatektomi yapılan hastalarda operasyon öncesi alınan prostatik üretra TUR biyopsilerin prostatik üretral tutulumu göstermedeki değeri ve intraoperatif prostatik üretral cerrahi sınır frozen biyopsiler ile birlikte diversiyon yönteminin seçimine etkisi ve üretral rekürrens araştırılmıştır. 35 erkek hasta çalışmaya dahil edildi. Tüm hastalardan sistoprostatektomi operasyonu öncesi prostatik üretral TUR biyopsi, ayrıca intraoperatif prostatik üretra cerrahi sınırdan frozen biyopsiler alındı. Radikal sistoprostatektomi materyallerinde; 9 hastada (%25,7) prostatik üretrada yüzeyel tutulum gözlenmiş, 26 hastada (%74,3) tutulum gözlenmemiştir. TUR prostatik biyopsilerin prostatik üretral tutulumu göstermedeki sensitivitesi %78, spesivitesi %92, pozitif prediktif değeri %78, negatif prediktif değeri % 92 dir. İntraoperatif prostatik üretra cerrahi sınır biyopsilerinden 33 ü (%94,3) negatif, 2 si (%5,7) pozitif bulunmuştur. Cerrahi sınır pozitif bulunan 2 hastada da prostatik üretral tutulum mevcuttu. Radikal sistoprostatektomi öncesi TUR prostatik üretral biyopsilerin prostatik üretral tutulumu göstermedeki değeri yüksektir ve operasyon öncesi hastaların üriner diversiyon tipi açısından bilgilendirilebilmesinde faydalıdır. Prostatik üretranın yüzeyel tutulumu üretrektomi için endikasyon olmamalı ve ortotopik diversiyon için engel teşkil etmemelidir. İntraoperatif postatik üretra cerrahi sınırdan frozen biyopsiler; prostatik üretra cerrahi sınırdaki tutulumu göstermede ve üretrektomi yapılma kararının verilmesinde, dolayısıyla ortotopik diversiyon tercihinde etkilidir. Anahtar Kelimeler: Mesane Kanseri, Prostatik Üretral TUR Biyopsi, Radikal Sistoprostatektomi, Üretral Frozen Biyopsi, Üretral Rekürrens * Ankara University Medical Faculty, Deparment of Urology, Resident ** Ankara University Medical Faculty, Deparment of Urology, Professor *** Ankara University Medical Facult, Deparment of Urology, Associate Professor Received: May 11, 2004 Accepted: May 28, 2004

2 14 THE VALUE OF PROSTATİC URETHRAL TUR BIOPSIES TAKEN BEFORE RADICAL CYSTOPROSTATECTOMY AND INTRAOPERATIVE FROZEN BIOPSY SAMPLES AND URETHRAL RECURRENCE Radical cystoprostatectomy with pelvic lymphadenectomy is the standart treatment for invasive bladder cancer. This treatment modality can be curative for early stage tumors and patients with limited extravesical and regional involvement (1). Therefore, radical cystectomy becomes the most effective treatment for invasive bladder cancer and as the orthotopic diversions with intact urethra used such common and become more popular, the position of the urethra has to be considered carefully. Most of the bladder tumors have urothelial origin, so the rest of the epithelium is under the risk of tumoral involvement or recurrence. After cystectomy, urethral recurrence risk of transitional cell carcinoma is 10 % in men (2). For urethral recurrence, most important risk factor is prostatic urethral involvement. In our study, TUR biopsies are taken before cystectomy to determine the involvement of transitional cell carcinoma to the prostatic urethra from the patients who had radical cystectomy because of invasive bladder cancer. These biopsies are compared with the pathology specimens of the cystoprostatectomy operation and the sensitivity, specificity and predictive values are determined. Also, the value of TUR biopsies from prostatic urethra and intraoperative prostatic urethral surgical margin frozen biopsies for determining the choice of diversion (orthotopic or heterotopic) and urethral recurrence is investigated. Material and Methods 35 male patients with the age of (mean 57.17) who had prostatic urethral TUR biopsies before cystoprostatectomy between January 1999 and June 2003 were included in our study. From all of the patients, intraoperative prostatic urthral surgical margin frozen biopsies were taken and evaluated. Clinical stages of all patients were determined with CT scans. After transurethral resection of bladder tumors, TUR biopsies were taken from 5 and 7 o clock positions of the prostatic urethra and the way between bladder neck and verumontanum. After histopathologic examination of cystoprostatectomy materials, patients were grouped as the patients with or without prostatic urethral involvement. The sensitivity, specificity and predictive values of TUR prostatic urethral biopsies and urethral recurrence, pathologic stage, grade and differences of follow-up periods are investigated. Within the follow-up period, patient history and complaints such as hematuria, urethral bleeding were investigated and physical examination with digital rectal examination, routine biochemical tests and abdominopelvic ultrasonography or CT were performed. Metastases and recurrences were followed-up. Intact urethra s were followed-up by digital rectal examination at each visit, and urine cytology in orthotopic diversions or urethral irrigation cytologies in heterotopic diversions. Patients were grouped according to prostatic urethral involvement. Fisher s Exact Test is used for comparing grades and stages and Mann- Whitney U Test is used for comparing follow-up periods between two groups. Results 9 (%25,7) of 35 TUR biopsies of prostatic urethra taken before radical cystectomy were positive for transitional cell carcinoma (TCC) and 26 ( % 74.3) were negative. All prostatic urethral involvement in TUR biopsy materials were superficial. In 9 (%25,7) patients there were prostatic urethral involvement at the pathological examination of cystoprostatectomy specimens (7 had positive prostatic TUR biopsies and 2 had negative). No prostatic urethral involvement was determined in 26 (% 74.3) patients (24 had negative prostatic TUR biopsies and 2 had positive). All prostatic involvements in cystectomy specimens were superficial. Prostatic urethral involvements in TUR prostatic biopsies and cystoprostatectomy specimens are shown in Table 1.

3 ÖZCAN KILIÇ, YAŞAR BEDÜK, KADİR TÜRKÖLMEZ, SÜMER BALTACI, C. ORHUN ECEMİŞ, MURAT AKAND, A. HAKAN HALİLOĞLU, HALİT TALAS 15 Table 1: Prostatic urethral involvement in TUR biopsies and cystoprostatectomy specimens. Prostatic Urethral Involvement In Cystoprostatectomy Specimen Negative Positive Total TUR Prostatic Biopsy Negative Positive Total The sensitivity of TUR prostatic biopsies for determining the prostatic urethral involvement was % 78, specificity was % 92; the positive predictive value is % 78 and the negative predictive value was % 92. False negative ratio of TUR prostatic biopsy was % 22 and false positive ratio was % 8. Frozen biopsies from the prostatic urethral surgical margin were taken in all patients during the cystoprostatectomy operation. In 33 (%94.3) patients surgical margin biopsies were negative and the remaining 2 patients (%5.7) were positive. After cystoprostatectomy operation 28 patients had orthotopic diversion, 5 patients had ileal conduit and 2 had continent rectal reservoir (Mainz Pouch II). 2 patients underwent uretrectomy simultaneous because of their positive frozen biopsy of the prostatic urethral surgical margin, and ileal conduit was selected as diversion method. Pathological examination confirmed TCC existence in both patients frozen biopsy. Diversion methods which had applied in the operation and prostatic urethral involvement are shown in table 2. Table 2: Prostatic urethral involvement and applied diversion methods. URINARY DIVERSION Orthotopic Ileal Conduit Continent Rectal Reservoir Total With psotatic involvement Without psotatic involvement Number of patient Uretrectomy 2 2

4 16 THE VALUE OF PROSTATİC URETHRAL TUR BIOPSIES TAKEN BEFORE RADICAL CYSTOPROSTATECTOMY AND INTRAOPERATIVE FROZEN BIOPSY SAMPLES AND URETHRAL RECURRENCE 7 patients of 9, whose TUR prostatic urethral biopsy was positive, had heterotopic diversion (5 ileal conduit including 2 patients who had urethrectomy, 2 continent rectal reservoir) and 2 patients had orthotopic diversion. According to pathological examination of cystoprostatectomy materials, prostatic urethral involvement was seen in 9 patients. Of these, 4 had orthotopic diversion, 4 had ileal conduit and 1 had continent rectal reservoir. TUR biopsy positiviness, prostatic urethral surgical margin involvement and patients preferences were the criterions to select diversion method. No statistically significance was found according to grade (in prostatic involvement group 4 grade II, 5 grade III; in the group without prostatic involvement 13 grade II, 13 grade III) (p 1) and stage (in prostatic involvement group 2 pt1, 4 pt2, 3 pt3; in the group without prostatic involvement 9 pt1, 11 pt2, 6 pt3) (p=0,665) in both groups with or without prostatic urethral involvement. The mean follow-up period of 26 patients who had no prostatic urethral involvement was 30.5 (5-54) months, and of 9 patients who had prostatic urethral involvement was 22.2 (6-45) months. There was no statistically significance between two groups (p= 0.19). One patient was lost to follow-up after 6 months. 2 of 9 patients with prostatic urethral involvement died (both of them due to pelvic recurrence and distant organ metastases), and 2 of 25 patients without prostatic urethral involvement died ( 1 due to pelvic recurrence, 1 due to another reason apart from his cancer) in follow-up period. All of the remaining 30 patients survived without any evidence of recurrence or metastases. No urethral recurrence was seen during the follow-up period in none of the 33 patients with intact urethra, except 2 patients who had urethrectomy. Conclusion There are two different approaches, preserving the bladder or radical cystectomy and urinary diversion, in the treatment of invasive bladder cancer. Radical cystectomy is still the standart treatment of invasive bladder cancer (3). Most of the patients prefer a normal life with a normal micturition pattern and a good voiding volume every 4-6 hours without a cutaneous stoma or external urostomy appatatus. Orthotopic substitution is the gold standart treatment method when compared with the other diversion methods (4). As radical cystectomy is an effective treatment for invasive bladder cancer and orthotopic diversion to naturel intact urethra is being done more frequently, the desting of the remaining urethra is becoming a more important issue (5). If there is a significant risk of tumor recurrence in the remaining urethra and local recurrence will affect the functional features of bladder potentially, orthotopic diversion should not be performed absolutely. Prostatic urethral involvement is the most important criterion for urethral tumor recurrence (5). Freeman et al. has reported anterior urethral tumor recurrence in 208 (10,1%) of 2062 patients who have undergone cystectomy (2). This figure provides a good estimate of the overall risk of developing an urethral recurrence after cystectomy for TCC of bladder. Hardeman and Soloway found anterior urethral recurrence in 11 (37%) of 30 patients with prostatic urethral tumors. No patient in this study with only prostatic urethral mucosa tumor developed a recurrence, whereas 25% of men with prostatic ductal involvement and 64% of men with prostatic stromal involvement in this report developed urethral recurrence. In the same series, only 2 of 56 patients (4%) whose tumors did not involve the prostatic urethra suffered urethral recurrence (6). Levinson and colleagues found 67% of urethral recurrences to be associated with prostatic urethral involvement, no patient whose tumor was confined to the prostatic urethral mucosa, 10% of patients prostatic ductal involvement and 30% of patients with prostatic stromal involvement developed a urethral recurrence(7). In our study no urethral recurrence was determined during the follow-up period in

5 ÖZCAN KILIÇ, YAŞAR BEDÜK, KADİR TÜRKÖLMEZ, SÜMER BALTACI, C. ORHUN ECEMİŞ, MURAT AKAND, A. HAKAN HALİLOĞLU, HALİT TALAS 17 patients who had superficial prostatic urtehral involvement and intact urethra. This result is concordant with the results of Hardeman and Soloway (6), Levinson et al. (7). Superficial urethral involvement should not be an indication for urethrectomy and hinder for orthotopic diversion. Patients with a tumor in any part of the prostate (prophilactic urethrectomy not performed after cutaneous diversion or has been follow-up after orthotopic diversion) have a significantly higher risk of urtehral recurrence. This risk increases significantly in patients with prostatic stromal involvement (5). It has been reported that deep TUR biopsies taken at the level of verumontanum, preferably at 5 hour and 7 hour position, may be helpful to define the prostatic urethral involvement (8,9). Lebret et al. found the sensitivity of preoperative TUR biopsy high, but the specificity low in their series of 118 cases. No urethral recurrence was found in 9 patients with positive biopsy but negative frozen biopsy in the urethral margin section. They have reported that the major risk factor is positive urethral margin, and if there is no evidence of tumor in intraoperative urethral frozen section biopsy (even if there is prostatic involvement) insidence of urethral recurrence after orthotopic diversion is low and preoperative prostate biopsy may not be necessary (10). Bulbul et al. have reported that TUR biopsy of the prostatic urethra prior to cystectomy, or biopsy of the prostatic urethral margin at the time of cystectomy in patients with cystoscopically normal, tumor free prostatic urethra has limited value in selecting candidates for orthotopic neobladder substitution (11). Presence of prostatic urethral tumor is accepted as a contraindication for constructing orthotopic bladder by most of investigators (7, 12, 13). Some investigators state that orthotopic substitution can be done if intraoperative frozen biopsy of prostatic urethral margin is negative (14). TUR prostatic biopsy before cystectomy or intraoperative frozen biopsy of prostatic urethra surgical margin are the best methods in excluding the disease and deciding the bladder substitution (15,16). Understanding that prostatic tumor involvement increases the risk of urethral tumor recurrence after radical cystectomy, we took TUR biopsy of prostatic urethra before radical cystoprostatectomy and intraoperative frozen biopsy from the surgical margin of prostatic urethra to identify these patients. It has found that the sensitivity of TUR prostatic biopsy was % 78 and the specificity was % 92. Our results show that the value of TUR biopsy of prostatic urethra before radical cystoprostatectomy in determining the prostatic urethral involvement is high. Presence of tumor in frozen biopsy from surgical margin of prostatic urethra can be accepted as a criterion for urethrectomy. Lebret et al. (10) have the same opinion. In our study, frozen biopsy from surgical margin of prostatic urethra is found in 2 of 9 patients with prostatic urethral involvement and these 2 patients underwent urethrectomy. Positiveness in surgical margin of prostatic urethra was not found in none of 26 patients with no involvement of prostatic urethra. Time to urethral cancer formation after cystectomy is generally 1-10 years (17), but most of them are seen in 5 years. In our study, of 28 patients (80%) performed orthotopic diversion (4 with prostatic urethral involvement and 24 without involvement) and of 7 patients (20%) performed heterotopic diversion (5 with prostatic urethral involvement and 2 without involvement), except 2 patients performed uretrectomy simultaneous because of prostatic urethral involvement and positive frozen biopsy, no urethral recurrence was observed in remaining 33 patient with intact urethra (7 with prostatic urethral involvement and 26 without involvement) for mean 26,36 months follow-up period. According to these results, for urethral recurrence, prostatic urethral involvement should not be an excluding criterion for orthotopic diversion; but positive surgical margin of

6 18 THE VALUE OF PROSTATİC URETHRAL TUR BIOPSIES TAKEN BEFORE RADICAL CYSTOPROSTATECTOMY AND INTRAOPERATIVE FROZEN BIOPSY SAMPLES AND URETHRAL RECURRENCE prostatic urethra should be considered as an excluding criterion for orthotopic diversion. However, the psycology of the patients have because of bladder cancer, is affected there more negatively because of organ loss when radical cystectomy is said indicated and offered. Most important anxiety of the patients is to survive close to their normal life in a disease free pattern. By this way, orthotopic diversions with normal micturation pattern reserved and without a cutaneous stoma or external urostomy apparatus should prefere primarly. The diversion method being uncertain before operation may affect patients negatively. For this reason despite it is stated by Lebret et al. (10) that positiveness of urethral margin is the major risk factor for urethral recurrence, according to our results we are in the opinion that orthotopic diversion can be performed to the patients with negative TUR biopsy if the intraoperative frozen biopsy is negative. Thus, patients can be informed about diversion method; this will help in reducing in the anxiety of patients who decided radical cystoprostatectomy. As a result, the value of TUR biopsy of prostatic urethra before cystectomy for determinig prostatic urethral involvement is high. It is observed that orthotopic diversion can be performed to all patients with negative TUR biopsy of prostatic urethra before radical cystectomy; orthotopic diversion can also be done in patients with positive TUR biopsy according to involvement of surgical margin of prostatic urethra. By this way, patients can be informed about diversion method before radical cystoprostatectomy. Intraoperative frozen biopsy from surgical margin of prostatic urethra is effective in deciding urethrectomy simultaneous, and also perefering orthotopic diversion.

7 ÖZCAN KILIÇ, YAŞAR BEDÜK, KADİR TÜRKÖLMEZ, SÜMER BALTACI, C. ORHUN ECEMİŞ, MURAT AKAND, A. HAKAN HALİLOĞLU, HALİT TALAS 19 References 1. Vieweg S, Gschwend JE, Herr HW, et al. Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol 1999; 161: Freeman JA, Esrig D, Stein JP, et al. Management of the patient with bladder cancer, urethral recurrence. Urol. Clin. North. Am 1994; 21: Kuczyk M, Turkeri L, Stein JP, et al. On behavior of the European Society for Oncological Urology: Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer?; European Urology 2003; 44: Hautman RE, Paiss T. Does the option of the ileal neobladder stimulate patient and physician decision toward earlier cystectomy. J Urol 1998; 159: Stein JP, Skinner DG. Orthotopic Urinary Diversion. Campbell s Urology, Eight eds. Philadelphia 2002 Vol: 4, pp Hardeman SW, Soloway MS. Urethral recurrence following radical cystectomy. J Urol 1990; 144: Levinson AK, Johnson DE, Wishnow KI. Indications for urethrectomy in an era of continent urinary diversion. J Urol 1990; 144: Wood DP Jr, Montie JE, Pontes JE, et al. Identification of transitional cell carcinoma of the prostate in bladder cancer patients: A prospective study. J Urol 1989; 142: Sakamoto N, Tsuneyoshi M, Naito S, et al. An adequate sampling of the prostate to identify prostatic involvement by urothelial carcinoma in bladder cancer patients. J Urol 1993;149: Lebret T, Herve JM, Barre P, et al. Urethral recurrence of transitional cell carcinoma of the bladder. Predictive value of preoperative lateromontanal biopsies and urethral frozen sections during prostatocystectomy. Eur Urol 1998; 33: Bulbul MA, Wazzan W, Nasr R, et al. The value of cystoscopy, prostate biopsy and frozen-section urethral biopsy prior to orthotopic neobladder substitution. The Can J Urol 2001; 8: Hardeman SW, Soloway MS. Urethral recurrence following radical cystectomy. J Urol 1990; 144: Tongaonkar HB, Dalad AV, Kulkami JN, et al. Urethral recurrences following radical cystectomy for invasive transitional cell carcinoma of the bladder. Br J Urol 1993; 72: Tarter TH, Freeman JA, Chen SC, et al. Urethral recurrence with ileal neobladders. J Urol 1995; Part 2, 153: 314A, Abstract Studer UE, Hautmann RE, Hohenfellner, et al. Indication for continent diversion following cystectomy and factors affecting long term results. Presented at fifth international consensus meeting on bladder cancer 1997, Tokoyo, Japan. 16. Skinner DJ, Studer UE, Aso OK, et al. Which patients are suitable for continent diversion or bladder substitution following cystectomy or other definitive local treatment. Int J Urol 1995; Suppl. 2: Tobisu K, Tanaka Y, Mizutani T, et al. Transitional carcinoma of the urethra in men following cystectomy for bladder cancer. Multivariate analysis for risk factors. J Urol 1991; 146:

Koji Ichihara Hiroshi Kitamura Naoya Masumori Fumimasa Fukuta Taiji Tsukamoto

Koji Ichihara Hiroshi Kitamura Naoya Masumori Fumimasa Fukuta Taiji Tsukamoto Int J Clin Oncol (2013) 18:75 80 DOI 10.1007/s10147-011-0346-8 ORIGINAL ARTICLE Transurethral prostate biopsy before radical cystectomy remains clinically relevant for decision-making on urethrectomy in

More information

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER 10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg

More information

Radical Cystectomy Often Too Late? Yes, But...

Radical Cystectomy Often Too Late? Yes, But... european urology 50 (2006) 1129 1138 available at www.sciencedirect.com journal homepage: www.europeanurology.com Editorial 50th Anniversary Radical Cystectomy Often Too Late? Yes, But... Urs E. Studer

More information

Radical cystectomy with or without urethrectomy?

Radical cystectomy with or without urethrectomy? Critical Reviews in Oncology/Hematology 47 (2003) 141/145 www.elsevier.com/locate/critrevonc Radical cystectomy with or without urethrectomy? Hein Van Poppel *, Tomas Sorgeloose Division of Urology, University

More information

Bladder replacement in men and women: when and when not? Outline. Continent Diversion History

Bladder replacement in men and women: when and when not? Outline. Continent Diversion History 1 Bladder replacement in men and women: when and when not? Eila C. Skinner, MD Professor of Clinical Urology Keck USC School of Medicine Outline 1) Selection criteria for orthotopic diversion: Tumor-related

More information

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER (Text update March 2008) A. Stenzl (chairman), N.C. Cowan, M. De Santis, G. Jakse, M. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, J.A. Witjes Introduction

More information

Optimal Timing of Radical Cystectomy for Patients with Invasive Transitional Cell Carcinoma of the Bladder

Optimal Timing of Radical Cystectomy for Patients with Invasive Transitional Cell Carcinoma of the Bladder Jpn J Clin Oncol 2002;32(1)14 18 Optimal Timing of Radical Cystectomy for Patients with Invasive Transitional Cell Carcinoma of the Bladder Isao Hara, Hideaki Miyake, Shoji Hara, Akinobu Gotoh, Hiroshi

More information

Anterior urethra sparing cystoprostatectomy for bladder cancer: a 10 year, single center experience

Anterior urethra sparing cystoprostatectomy for bladder cancer: a 10 year, single center experience DOI 10.1186/s40064-015-1200-7 RESEARCH Open Access Anterior urethra sparing cystoprostatectomy for bladder cancer: a 10 year, single center experience Nozomi Hayakawa 1,2*, Nobuyuki Kikuno 1,2, Hiroki

More information

INCIDENTAL PROSTATE CANCER IN PATIENTS UNDERGOING RADICAL CYSTOPROSTATECTOMY FOR BLADDER CANCER

INCIDENTAL PROSTATE CANCER IN PATIENTS UNDERGOING RADICAL CYSTOPROSTATECTOMY FOR BLADDER CANCER & INCIDENTAL PROSTATE CANCER IN PATIENTS UNDERGOING RADICAL CYSTOPROSTATECTOMY FOR BLADDER CANCER Mustafa Hiroš *, Hajrudin Spahović, Mirsad Selimović, Sabina Sadović Urology Clinic, University of Sarajevo

More information

Urethral recurrence after cystectomy: current preventative measures, diagnosis and management

Urethral recurrence after cystectomy: current preventative measures, diagnosis and management Urethral recurrence after cystectomy: current preventative measures, diagnosis and management Yvonne Chan*, Patrick Fisher*, Derya Tilki* and Christopher P.Evans* *Department of Urology, Medical Center,

More information

Bladder Cancer Guidelines

Bladder Cancer Guidelines Bladder Cancer Guidelines Agreed by Urology CSG: October 2011 Review Date: September 2013 Bladder Cancer 1. Referral Guidelines The following patients should be considered as potentially having bladder

More information

Urethral Carcinoma Recurrence in Ileal Orthotopic Neobladder: Urethrectomy and Conversion in a Continent Pouch with Abdominal Stoma

Urethral Carcinoma Recurrence in Ileal Orthotopic Neobladder: Urethrectomy and Conversion in a Continent Pouch with Abdominal Stoma Case Report Urol Int 1999;62:213 216 Received: June 19, 1998 Accepted after revision: March 8, 1999 Urethral Carcinoma Recurrence in Ileal Orthotopic Neobladder: Urethrectomy and Conversion in a Continent

More information

Staging and Grading Last Updated Friday, 14 November 2008

Staging and Grading Last Updated Friday, 14 November 2008 Staging and Grading Last Updated Friday, 14 November 2008 There is a staging graph below Blood in the urine is the most common indication that something is wrong. Often one will experience pain or difficulty

More information

Joseph H. Williams, MD Idaho Urologic Institute St. Alphonsus Regional Medical Center September 22, 2016

Joseph H. Williams, MD Idaho Urologic Institute St. Alphonsus Regional Medical Center September 22, 2016 BLADDER CANCER Joseph H. Williams, MD Idaho Urologic Institute St. Alphonsus Regional Medical Center September 22, 2016 BLADDER CANCER = UROTHELIAL CANCER Antiquated term is Transitional Cell Carcinoma

More information

TCC recurrence within the upper tract urothelium following

TCC recurrence within the upper tract urothelium following Upper Tract Urothelial Recurrence Following Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: An Analysis of 1,069 Patients With 10-Year Followup Kristin M. Sanderson,* Jie Cai, Gustavo

More information

Clinical Study of G3 Superficial Bladder Cancer without Concomitant CIS Treated with Conservative Therapy

Clinical Study of G3 Superficial Bladder Cancer without Concomitant CIS Treated with Conservative Therapy Jpn J Clin Oncol 2002;32(11)461 465 Clinical Study of G3 Superficial Bladder Cancer without Concomitant CIS Treated with Conservative Therapy Takashi Saika, Tomoyasu Tsushima, Yasutomo Nasu, Ryoji Arata,

More information

Partial Cystectomy for Invasive Bladder Cancer

Partial Cystectomy for Invasive Bladder Cancer European Urology Supplements European Urology Supplements 4 (2005) 67 71 Partial Cystectomy for Invasive Bladder Cancer Gerald H. Mickisch* Center of Operative Urology Bremen, Academic Hospital Bremen

More information

Radical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors

Radical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors ORIGINAL ARTICLE Radical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors Chen-Hsun Ho, 1,2 Chao-Yuan Huang, 1 Wei-Chou Lin, 3 Shih-Chieh Chueh, 1 Yeong-Shiau

More information

Running head: Treatment modality and long term renal function in MIBC-Hamidi et al.

Running head: Treatment modality and long term renal function in MIBC-Hamidi et al. Running head: Treatment modality and long term renal function in MIBC-Hamidi et al. Effect of Treatment Modality on Long Term Renal Functions in Patients With Muscle Invasive Bladder Cancer Nurullah Hamidi

More information

When to Integrate Surgery for Metatstatic Urothelial Cancers

When to Integrate Surgery for Metatstatic Urothelial Cancers When to Integrate Surgery for Metatstatic Urothelial Cancers Wade J. Sexton, M.D. Senior Member and Professor Department of Genitourinary Oncology Moffitt Cancer Center Case Presentation #1 67 yo male

More information

A Fourteen-Year Review of Radical Cystectomy for Transitional Cell Carcinoma Demonstrating the Usefulness of the Concept of Lymph Node Density

A Fourteen-Year Review of Radical Cystectomy for Transitional Cell Carcinoma Demonstrating the Usefulness of the Concept of Lymph Node Density Clinical Urology TCC of the Bladder and Lymph Node Density International Braz J Urol Vol. 32 (5): 536-549, September - October, 2006 A Fourteen-Year Review of Radical Cystectomy for Transitional Cell Carcinoma

More information

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER (Limited text update December 21) M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, J. Palou, M. Rouprêt Eur Urol 211 Apr;59(4):584-94 Introduction

More information

Sexuality Preserving Cystectomy and Neobladder (SPCN): Functional Results of a Neobladder Anastomosed to the Prostate

Sexuality Preserving Cystectomy and Neobladder (SPCN): Functional Results of a Neobladder Anastomosed to the Prostate European Urology European Urology 43 (2003) 646 650 Sexuality Preserving Cystectomy and Neobladder (SPCN): Functional Results of a Neobladder Anastomosed to the Prostate W. Meinhardt *, S. Horenblas Department

More information

URINARY DIVERSIONS. Winter 2016 Dr P. O Malley

URINARY DIVERSIONS. Winter 2016 Dr P. O Malley URINARY DIVERSIONS Winter 2016 Dr P. O Malley OVERVIEW Who gets diversions? What s involved with cystectomy? What are the different types of diversions? What are the problems with various diversions? How

More information

Recovery of sexual function after radical cystectomy with orthotopic neobladder

Recovery of sexual function after radical cystectomy with orthotopic neobladder Recovery of sexual function after radical cystectomy with orthotopic neobladder C. Gingu, V. Olaru, A. Dick, C. Baston, M. Crăsneanu, C. Surcel, S. Voinea, Liliana Domnişor, I. Sinescu Center of Urological

More information

Haijun Zhou, Jae Y Ro, Luan D Truong, Alberto G Ayala, Steven S Shen

Haijun Zhou, Jae Y Ro, Luan D Truong, Alberto G Ayala, Steven S Shen Am J Clin Exp Urol 2014;2(2):156-160 www.ajceu.us /ISSN:2330-1910/AJCEU0000048 Original Article Intraoperative frozen section evaluation of ureteral and urethral margins: studies of 203 consecutive radical

More information

Open Radical Cystectomy Tips and Tricks in Males and Females

Open Radical Cystectomy Tips and Tricks in Males and Females Open Radical Cystectomy Tips and Tricks in Males and Females Seth P. Lerner, MD, FACS Professor of Urology Beth and Dave Swalm Chair in Urologic Oncology Scott Department of Urology Baylor College of Medicine

More information

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series Collecting Cancer Data Bladder & Renal Pelvis NAACCR 2012 2013 Webinar Series Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching

More information

The Predictors of Local Recurrence after Radical Cystectomy in Patients with Invasive Bladder Cancer

The Predictors of Local Recurrence after Radical Cystectomy in Patients with Invasive Bladder Cancer The Predictors of Local Recurrence after Radical Cystectomy in Patients with Invasive Bladder Cancer Hiroki Ide, Eiji Kikuchi, Akira Miyajima, Ken Nakagawa, Takashi Ohigashi, Jun Nakashima and Mototsugu

More information

Radical cystectomy for bladder cancer: oncologic outcome in 271 Chinese patients

Radical cystectomy for bladder cancer: oncologic outcome in 271 Chinese patients Original Article : oncologic outcome in 271 Chinese patients Zhi-Ling Zhang, Pei Dong, Yong-Hong Li, Zhuo-Wei Liu, Kai Yao, Hui Han, Zi-Ke Qin and Fang-Jian Zhou Abstract Few large scale studies have reported

More information

5/26/16: CT scan of the abdomen showed a multinodular liver disease highly suspicious for metastasis and hydronephrosis of the right kidney.

5/26/16: CT scan of the abdomen showed a multinodular liver disease highly suspicious for metastasis and hydronephrosis of the right kidney. Bladder Case Scenario 1 History 5/23/16: A 52-year-old male, smoker was admitted to our hospital with a 3-month history of right pelvic pain, multiple episodes of gross hematuria, dysuria, and extreme

More information

Glossary of Terms Primary Urethral Cancer

Glossary of Terms Primary Urethral Cancer Patient Information English Glossary of Terms Primary Urethral Cancer Advanced cancer A tumour that grows into deeper layers of tissue, adjacent organs, or surrounding muscles. Anaesthesia (general, spinal,

More information

Superficial Urothelial Cancer in the Prostatic Urethra

Superficial Urothelial Cancer in the Prostatic Urethra Review Article Superficial Bladder Cancer TheScientificWorldJOURNAL (2006) 6, 2603 2610 TSW Urology ISSN 1537-744X; DOI 10.1100/tsw.2006.402 Superficial Urothelial Cancer in the Prostatic Urethra Ziya

More information

Bone Metastases in Muscle-Invasive Bladder Cancer

Bone Metastases in Muscle-Invasive Bladder Cancer Journal of the Egyptian Nat. Cancer Inst., Vol. 18, No. 3, September: 03-08, 006 AZZA N. TAHER, M.D.* and MAGDY H. KOTB, M.D.** The Departments of Radiation Oncology* and Nuclear Medicine**, National Cancer

More information

Urological Tumours 1 Kidney tumours 2 Bladder tumours

Urological Tumours 1 Kidney tumours 2 Bladder tumours Urological Tumours 1 Kidney tumours 2 Bladder tumours Tim Bracey SpR Histopathology Derriford Hospital Kidney tumours What are we going to talk about?! Anatomy of urinary tract! Types of kidney tumours!

More information

REVIEW. Patterns of recurrence of bladder carcinoma following radical cystectomy

REVIEW. Patterns of recurrence of bladder carcinoma following radical cystectomy Cancer Imaging (2003) 3, 96 100 DOI: 10.1102/1470-7330.2003.0009 CI REVIEW Patterns of recurrence of bladder carcinoma following radical cystectomy D M Koh and J E Husband Academic Department of Radiology,

More information

Genital organ involvement in female patients with bladder cancer: evaluation of radical cystectomy specimens

Genital organ involvement in female patients with bladder cancer: evaluation of radical cystectomy specimens Türk Üroloji Dergisi - Turkish Journal of Urology 2009;35(4):269-273 269 Urooncology Üroonkoloji Genital organ involvement in female patients with bladder cancer: evaluation of radical cystectomy specimens

More information

Impact of invasive bladder cancer and orthotopic urinary diversion on general health-related quality of life: An SF-36 survey

Impact of invasive bladder cancer and orthotopic urinary diversion on general health-related quality of life: An SF-36 survey 758 Impact of invasive bladder cancer and orthotopic urinary diversion on general health-related quality of life: An SF-36 survey MINGYING YANG 1,2*, HAIFENG WANG 2*, JIANSONG WANG 2 and MINGHUI RUAN 1

More information

Trimodality Therapy for Muscle Invasive Bladder Cancer

Trimodality Therapy for Muscle Invasive Bladder Cancer Trimodality Therapy for Muscle Invasive Bladder Cancer Brita Danielson, MD, FRCPC Radiation Oncologist, Cross Cancer Institute Assistant Professor, Department of Oncology University of Alberta Edmonton,

More information

Carcinoma of the Urinary Bladder Histopathology

Carcinoma of the Urinary Bladder Histopathology Carcinoma of the Urinary Bladder Histopathology Reporting Proforma (Radical & Partial Cystectomy, Cystoprostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family

More information

Eiji Kikuchi, Yutaka Horiguchi, Jun Nakashima, Takashi Ohigashi, Mototsugu Oya, Ken Nakagawa, Akira Miyajima and Masaru Murai

Eiji Kikuchi, Yutaka Horiguchi, Jun Nakashima, Takashi Ohigashi, Mototsugu Oya, Ken Nakagawa, Akira Miyajima and Masaru Murai Assessment of Long-Term Quality of Life Using the FACT-BL Questionnaire in Patients with an Ileal Conduit, Continent Reservoir, or Orthotopic Neobladder Eiji Kikuchi, Yutaka Horiguchi, Jun Nakashima, Takashi

More information

Surgical Management of Bladder Carcinoma

Surgical Management of Bladder Carcinoma The critical principles and controversies in both the endoscopic and open surgical approaches to superficial and invasive bladder cancer are reviewed. Anita Philyaw. Bookmark (detail), 2000. Acrylic on

More information

BLADDER CANCER CONTENT CREATED BY. Learn more at

BLADDER CANCER CONTENT CREATED BY. Learn more at BLADDER CANCER CONTENT CREATED BY Learn more at www.health.harvard.edu TALK TO YOUR DOCTOR Table of Contents WHAT IS BLADDER CANCER? 4 TYPES OF BLADDER CANCER 5 GRADING AND STAGING 8 TREATMENT OVERVIEW

More information

Dr. Tareq Salah Ahmed,MD,ESMO. Lecturer of clinical oncology, Assiut faculty of medicine ESMO accreditation certificate

Dr. Tareq Salah Ahmed,MD,ESMO. Lecturer of clinical oncology, Assiut faculty of medicine ESMO accreditation certificate Dr. Tareq Salah Ahmed,MD,ESMO Lecturer of clinical oncology, Assiut faculty of medicine ESMO accreditation certificate 1 st Assiut Urology department conference,marsa Alam 3 rd February 2015 Bladder cancer

More information

Attachment #2 Overview of Follow-up

Attachment #2 Overview of Follow-up Attachment #2 Overview of Follow-up Provided below is a general overview of follow-up and this may vary based on specific patient or cancer characteristics. Of note, Labs and imaging can be performed closer

More information

Metachronous anterior urethral metastasis of prostatic ductal adenocarcinoma

Metachronous anterior urethral metastasis of prostatic ductal adenocarcinoma http://dx.doi.org/10.7180/kmj.2016.31.1.66 KMJ Case Report Metachronous anterior urethral metastasis of prostatic ductal adenocarcinoma Jeong Hyun Oh 1, Taek Sang Kim 1, Hyun Yul Rhew 1, Bong Kwon Chun

More information

American Journals of Cancer Case Reports. A Rare Case of Rectal Metastasis from Sarcomatoid Variant of Urothelial Carcinoma: A Case Report

American Journals of Cancer Case Reports. A Rare Case of Rectal Metastasis from Sarcomatoid Variant of Urothelial Carcinoma: A Case Report American Journals of Cancer Case Reports Lin JYJ et al. American Journals of Cancer Case Reports 2014, 3:1-5 http://ivyunion.org/index.php/ajccr Page 1 of 5 Vol 3 Article ID 20140539, 5 pages Case Report

More information

Organ-sparing treatment of invasive transitional cell bladder carcinoma

Organ-sparing treatment of invasive transitional cell bladder carcinoma Journal of BUON 7: 241-245, 2002 2002 Zerbinis Medical Publications. Printed in Greece ORIGINAL ARTICLE Organ-sparing treatment of invasive transitional cell bladder carcinoma C. Damyanov, B. Tsingilev,

More information

Early radical cystectomy in NMIBC Marko Babjuk

Early radical cystectomy in NMIBC Marko Babjuk Early radical cystectomy in NMIBC Marko Babjuk Dept. of Urology, 2nd Faculty of Medicine, Hospital Motol, Praha, Czech Republic We Are The European Association of Urology We Are Urologists, residents,

More information

Comparison of Three Types of Continent Urinary Diversions in a Single Center

Comparison of Three Types of Continent Urinary Diversions in a Single Center Article TheScientificWorldJOURNAL (2004) 4 (S1), 135 141 ISSN 1537-744X; DOI 10.1100/tsw.2004.59 Comparison of Three Types of Continent Urinary Diversions in a Single Center Cengiz Girgin, M.D., Akif Sezer,

More information

Cystectomies and bladder preservation: What you need to know

Cystectomies and bladder preservation: What you need to know Cystectomies and bladder preservation: What you need to know Robin Morash RN, BNSc, MHS Bladder Cancer Canada November 21, 2018 Presentation goals Review the options for treatment of muscle-invasive bladder

More information

Part II: Treatment. A Woman-to-Woman Talk with Dr. Armine Smith. Wednesday, March 8, Presented by

Part II: Treatment. A Woman-to-Woman Talk with Dr. Armine Smith. Wednesday, March 8, Presented by Women & Bladder Cancer A Woman-to-Woman Talk with Dr. Armine Smith Wednesday, March 8, 2017 Part II: Treatment Presented by Dr. Smith is an Assistant Professor of Urology at Johns Hopkins University and

More information

URINARY DIVERSIONS. Susan Hilton, MD and Nicholas Papanicolaou, MD Co-Chiefs, CT Section Hospital of the University of Pennsylvania

URINARY DIVERSIONS. Susan Hilton, MD and Nicholas Papanicolaou, MD Co-Chiefs, CT Section Hospital of the University of Pennsylvania URINARY DIVERSIONS Susan Hilton, MD and Nicholas Papanicolaou, MD Co-Chiefs, CT Section Hospital of the University of Pennsylvania Neither of us has any financial relationships with commercial interests

More information

UNDERSTANDING BLADDER CANCER

UNDERSTANDING BLADDER CANCER UNDERSTANDING BLADDER CANCER Learn About Your Treatment Options After Your Diagnosis If your doctor has told you that you have bladder cancer, you likely have many questions and concerns. Learning about

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research   ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Outcome of Open Radical Cystectomy and Ileal Conduit: A Single Center Experience Mahesh Kalloli

More information

Cystoscopy in children presenting with hematuria should not be overlooked

Cystoscopy in children presenting with hematuria should not be overlooked Ped Urol Case Rep 2015; 2(3):7-11 DOI: 10.14534/PUCR.2015310303 PUCR Ped Urol Case Rep PEDIATRIC UROLOGY CASE REPORTS ISSN: 2148 2969 Journal homepage: http://www.pediatricurologycasereports.com Cystoscopy

More information

ATinyIncredibleUrethralCarcinomaDimensionmaybeDeceptiveACaseReport

ATinyIncredibleUrethralCarcinomaDimensionmaybeDeceptiveACaseReport : F Diseases Volume 16 Issue 1 Version 1.0 Year 2016 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc. (USA) Online ISSN: 2249-4618 & Print ISSN: 0975-5888

More information

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline Jeffrey M. Holzbeierlein, MD, FACS John W Weigel Professor & Chair Director of Urologic Oncology University of Kansas

More information

A patient with recurrent bladder cancer presents with the following history:

A patient with recurrent bladder cancer presents with the following history: MP/H Quiz A patient with recurrent bladder cancer presents with the following history: 9/23/06 TURB 1/12/07 TURB 4/1/07 TURB 7/12/07 TURB 11/14/07 Non-invasive papillary transitional cell carcinoma from

More information

Case 1. Receives induction BCG weekly x 6 without significant toxicity Next step should be:

Case 1. Receives induction BCG weekly x 6 without significant toxicity Next step should be: Case 1 89 year old male with initial occurrence of gross hematuria Office flexible cystoscopy shows two papillary tumors with some surface necrosis Complete TURBT into muscle Florescence cysto shows two

More information

ROBOTIC VS OPEN RADICAL CYSTECTOMY

ROBOTIC VS OPEN RADICAL CYSTECTOMY ROBOTIC VS OPEN RADICAL CYSTECTOMY A REVIEW Colin Lundeen December 14, 2016 Objectives Review the history of radical cystectomy Critically analyze recent RCTs comparing open radical cystectomy (ORC) to

More information

Bladder Cancer Canada November 21st, Bladder Cancer 2018: A brighter light at the end of the cystoscope

Bladder Cancer Canada November 21st, Bladder Cancer 2018: A brighter light at the end of the cystoscope Bladder Cancer Canada November 21st, 2018 Bladder Cancer 2018: A brighter light at the end of the cystoscope Chris Morash MD FRCSC Associate Professor, University of Ottawa Head, Urological Oncology Bladder

More information

A Personal History NIH CWRU U of TN U of Miami Animal Model for Bladder Cancer Carcinogen induced FANFT Three Models Primary tumors individual tumors, simulates clinical scenario of locally advanced cancer

More information

Panel: A Case-based Approach to the Management of Bladder Cancer

Panel: A Case-based Approach to the Management of Bladder Cancer Panel: A Case-based Approach to the Management of Bladder Cancer ~ Moderator: Robert Donohue, MD Panel: David C. Beyer, MD E. David Crawford, MD Donald L. Lamm, MD Paul D. Maroni, MD TCC Cases Robert E.

More information

Information for Patients. Primary urethral cancer. English

Information for Patients. Primary urethral cancer. English Information for Patients Primary urethral cancer English Table of contents What is primary urethral cancer?... 3 Risk factors... 3 Symptoms... 4 Diagnosis... 4 Clinical examination... 4 Urinary cytology...

More information

Chapter 1: General Introduction and Outline of the Thesis

Chapter 1: General Introduction and Outline of the Thesis Chapter 1: General Introduction and Outline of the Thesis General Introduction and Outline of the Thesis Introduction In the Netherlands radical cystectomy is the gold standard treatment for therapy resistant

More information

BLADDER CANCER: PATIENT INFORMATION

BLADDER CANCER: PATIENT INFORMATION BLADDER CANCER: PATIENT INFORMATION The bladder is the balloon like organ located in the pelvis that stores and empties urine. Urine is produced by the kidneys, is conducted to the bladder by the ureters,

More information

Is partial cystectomy an oncologically viable option for primary urachal adenocarcinoma?

Is partial cystectomy an oncologically viable option for primary urachal adenocarcinoma? ORIGINAL ARTICLE Is partial cystectomy an oncologically viable option for primary urachal adenocarcinoma? Sebastian Mafeld, Nikhil Vasdev, Andrew C Thorpe Department of Urology, Freeman Hospital, Newcastle

More information

Muscle-invasive bladder cancer

Muscle-invasive bladder cancer Patient Information English 4 Muscle-invasive bladder cancer The underlined terms are listed in the glossary. What is muscle-invasive bladder cancer? About a quarter of patients diagnosed with bladder

More information

Influence of stage discrepancy on outcome in. in patients treated with radical cystectomy.

Influence of stage discrepancy on outcome in. in patients treated with radical cystectomy. Tumori, 96: 699-703, 2010 Influence of stage discrepancy on outcome in patients treated with radical cystectomy Ja Hyeon Ku 1, Kyung Chul Moon 2, Cheol Kwak 1, and Hyeon Hoe Kim 1 1 Department of Urology,

More information

Lymphadenectomy with Cystectomy: Is It Necessary

Lymphadenectomy with Cystectomy: Is It Necessary European Urology European Urology 46 (2004) 457 461 Lymphadenectomy with Cystectomy: Is It Necessary and What Is Its Extent? Mohamed A. Ghoneim *, Hassan Abol-Enein Urology & Nephrology Center, Gomhouria

More information

Diagnosis and classification

Diagnosis and classification Patient Information English 2 Diagnosis and classification The underlined terms are listed in the glossary. Signs and symptoms Blood in the urine is the most common symptom when a bladder tumour is present.

More information

Chapter 8: Urinary Diversions after Cystectomy: The Association of Clinical Factors, Complications and Functional Results of Four Different Diversions

Chapter 8: Urinary Diversions after Cystectomy: The Association of Clinical Factors, Complications and Functional Results of Four Different Diversions Chapter 8: Urinary Diversions after Cystectomy: The Association of Clinical Factors, Complications and Functional Results of Four Different Diversions J.A. Nieuwenhuijzen* R.R. de Vries* A. Bex H.G. van

More information

URETHRAL CANCER EPIDEMIOLOGY - 1

URETHRAL CANCER EPIDEMIOLOGY - 1 URETHRAL CANCER Diagnosis & Management Case Conferences Jennie Mickelson Grand Rounds November 15, 2006 EPIDEMIOLOGY - 1 RARE 2200 reported cases F:M - 4:1 1 FEMALE URETHRAL CA any age but >60 most common

More information

Bladder Cancer: Overview, diagnosis and treatment with a focus on outpatient clinical issues

Bladder Cancer: Overview, diagnosis and treatment with a focus on outpatient clinical issues Bladder Cancer: Overview, diagnosis and treatment with a focus on outpatient clinical issues William F. Santis, M.D. Concord Hospital Center for Urologic Care September 28, 2013 Goals: Overview of bladder

More information

Attachment #2 Overview of Follow-up

Attachment #2 Overview of Follow-up Attachment #2 Overview of Follow-up Provided below is a general overview of follow-up and this may vary based on specific patient or cancer characteristics. Of note, Labs and imaging can be performed closer

More information

Lymph node dissection: how much is enough?

Lymph node dissection: how much is enough? 1 Background Lymph node dissection: how much is enough? Eila C. Skinner, MD Professor of Clinical Urology USC Keck School of Medicine Radical cystectomy is the gold standard for the treatment of invasive

More information

1. Introduction. 2. Methods. high-risk NMIBC in men with and without a prior history of RT for PC.

1. Introduction. 2. Methods. high-risk NMIBC in men with and without a prior history of RT for PC. ISRN Urology Volume 2013, Article ID 405064, 5 pages http://dx.doi.org/10.1155/2013/405064 Research Article Radical Cystectomy after BCG Immunotherapy for High-Risk Nonmuscle-Invasive Bladder Cancer in

More information

Functional and Clinical Outcome of Ileal (Studer) Neo-bladder Reconstruction: Single Centre Experience from Pakistan

Functional and Clinical Outcome of Ileal (Studer) Neo-bladder Reconstruction: Single Centre Experience from Pakistan ORIGINAL ARTICLE Functional and Clinical Outcome of Ileal (Studer) Neo-bladder Reconstruction: Single Centre Experience from Pakistan Syed M. Nazim, M. Hammad Ather and Farhat Abbas ABSTRACT Objective:

More information

NMIBC. Piotr Jarzemski. Department of Urology Jan Biziel University Hospital Bydgoszcz, Poland

NMIBC. Piotr Jarzemski. Department of Urology Jan Biziel University Hospital Bydgoszcz, Poland NMIBC Piotr Jarzemski Department of Urology Jan Biziel University Hospital Bydgoszcz, Poland 71 year old male patient was admitted to the Department of Urology First TURBT - 2 months prior to the hospitalisation.

More information

MEDitorial March Bladder Cancer

MEDitorial March Bladder Cancer MEDitorial March 2010 Bladder Cancer Last month, my article addressed the issue of blood in the urine ( hematuria ). A concerning cause of hematuria is bladder cancer, a variably malignant tumor starting

More information

EAU MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

EAU MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER EAU MUSLE-INVASIVE AND METASTATI LADDER ANER (Limited text update March 2016) J.A. Witjes (hair), E. ompérat, N.. owan, M. De Santis, G. Gakis, N. James, T. Lebret, A.G. van der Heijden, M.J. Ribal Guidelines

More information

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR Last Revision Date July 2015 1 Site Group: Gynecologic Cancer Vulvar Author: Dr. Stephane Laframboise 1. INTRODUCTION

More information

BLADDER HEALTH. Muscle Invasive Bladder Cancer: A Patient Guide

BLADDER HEALTH. Muscle Invasive Bladder Cancer: A Patient Guide BLADDER HEALTH Muscle Invasive Bladder Cancer: A Patient Guide Table of Contents Bladder Cancer Expert Panel Mike's Story: A Patient Story.... Introduction.... GET THE FACTS What is bladder cancer?....

More information

Chemotherapy and Bladder Cancer. Blayne Welk UBC Urology Grand Rounds June 4, 2008

Chemotherapy and Bladder Cancer. Blayne Welk UBC Urology Grand Rounds June 4, 2008 Chemotherapy and Bladder Cancer Blayne Welk UBC Urology Grand Rounds June 4, 2008 Outline Review of Incidence and Impact of bladder cancer Neoadjuvant chemotherapy Adjuvant chemotherapy Bladder preservation

More information

Microscopic Study of Histological Changes the Use of Ileal Mucosa as a Bladder (Radical Cystectomy - Case Report)

Microscopic Study of Histological Changes the Use of Ileal Mucosa as a Bladder (Radical Cystectomy - Case Report) Microscopic Study of Histological Changes the Use of Ileal Mucosa as a Bladder (Radical Cystectomy - Case Report) Sareh Najaf Asaadi, Hassan Morovvati, Ahmad Reza Taftachi International Journal of Advanced

More information

Bladder Sparing Treatment of Muscle Invasive Bladder Cancer

Bladder Sparing Treatment of Muscle Invasive Bladder Cancer Bladder Sparing Treatment of Muscle Invasive Bladder Cancer Pr Alexandre de la Taille CHU Mondor, Créteil INSERMU955Eq07 adelataille@hotmail.com High-Risk Invasive and Muscle-Invasive BCa Radical cystectomy

More information

Multiple factor analysis of metachronous upper urinary tract transitional cell carcinoma after radical cystectomy

Multiple factor analysis of metachronous upper urinary tract transitional cell carcinoma after radical cystectomy Brazilian Journal of Medical and Biological Research (2007) 40: 979-984 Predictive factors after radical cystectomy ISSN 0100-879X 979 Multiple factor analysis of metachronous upper urinary tract transitional

More information

A215- Urinary bladder cancer tissues

A215- Urinary bladder cancer tissues A215- Urinary bladder cancer tissues (formalin fixed) For research use only Specifications: No. of cases: 45 Tissue type: Urinary bladder cancer tissues No. of spots: 2 spots from each cancer case (90

More information

3.1 Investigations for Patients Presenting with Haematuria Table 1

3.1 Investigations for Patients Presenting with Haematuria Table 1 3.1 Investigations for Patients Presenting with Haematuria Table 1 Patients at risk of bacterial endocarditis should be given antibiotic prophylaxis as per local guidelines. Patients with heart valve replacements

More information

The pathology of bladder cancer

The pathology of bladder cancer 1 The pathology of bladder cancer Charles Jameson Introduction Carcinoma of the bladder is the seventh most common cancer worldwide [1]. It comprises 3.2% of all cancers, with an estimated 260 000 new

More information

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram Proposed All Wales Vulval Cancer Guidelines Dr Amanda Tristram Previous FIGO staging FIGO Stage Features TNM Ia Lesion confined to vulva with

More information

Prostate Overview Quiz

Prostate Overview Quiz Prostate Overview Quiz 1. The path report reads: Gleason 3 + 4 = 7. The Gleason s score is a. 3 b. 4 c. 7 d. None of the above 2. The path report reads: Moderately differentiated adenocarcinoma of the

More information

UROTHELIAL CELL CANCER

UROTHELIAL CELL CANCER UROTHELIAL CELL CANCER Indications and regimens for neoadjuvant systemic treatment Astrid A. M. van der Veldt, MD, PhD, medical oncologist Department of Medical Oncology Erasmus Medical Center Cancer Institute

More information

Abstract. Original Article

Abstract. Original Article Original Article Middle East Journal of Cancer; July 2015; 6(3): 165-170 A Comparison of Early Results and Patient Satisfaction Rate between Modified Radical Cystectomy with Mainz II Urinary Diversion

More information

Information for Patients. Bladder Cancer. English

Information for Patients. Bladder Cancer. English Information for Patients Bladder Cancer English Table of contents What is the function of the bladder?... 3 What is bladder cancer?... 3 What causes bladder cancer?... 3 Stages of the disease... 3 Risk

More information

Do Patients Benefit from Routine Follow-up to Detect Recurrences After Radical Cystectomy and Ileal Orthotopic Bladder Substitution?

Do Patients Benefit from Routine Follow-up to Detect Recurrences After Radical Cystectomy and Ileal Orthotopic Bladder Substitution? EUROPEAN UROLOGY 58 (2010) 486 494 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Bladder Cancer Editorial by Renzo Colombo on pp. 495 497 of this issue

More information

Body Image Following Radical Cystectomy and Ileal Neobladder or Conduit in Korean Patients

Body Image Following Radical Cystectomy and Ileal Neobladder or Conduit in Korean Patients www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.3.161 Original Article - Urological Oncology http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.3.161&domain=pdf&date_stamp=2014-03-17

More information

Citation International journal of urology (2. Right which has been published in final f

Citation International journal of urology (2.  Right which has been published in final f Title Novel constant-pressure irrigation of renal pelvic tumors after ipsila Nakamura, Kenji; Terada, Naoki; Sug Author(s) Toshinori; Matsui, Yoshiyuki; Imamu Kazutoshi; Kamba, Tomomi; Yoshimura Citation

More information